Turn Therapeutics Inc Common Stock

Yahoo Finance • 2 months ago

Turn Therapeutics Inc. Non-GAAP EPS of -$0.07

* Turn Therapeutics Inc. press release [https://seekingalpha.com/pr/20306010-turn-therapeutics-reports-third-quarter-2025-financial-results-and-provides-corporate-updates] (TTRX [https://seekingalpha.com/symbol/TTRX]): Q3 Non-GAAP EPS of... Full story

Yahoo Finance • 2 months ago

Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications

LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced the appointment of An... Full story

Yahoo Finance • 3 months ago

Turn Therapeutics Provides Shareholder Update Highlighting Continued Execution Across Clinical and Strategic Milestones

WESTLAKE VILLAGE, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (Nasdaq: TTRX) (“Turn” or the “Company”), a clinical-stage biotechnology company developing next-generation dermatology, wound, and anti-infective therapies, p... Full story

Yahoo Finance • 3 months ago

Turn Therapeutics Launches Webinar Series for Ongoing Shareholder Engagement, First Session October 22, 2025

LOS ANGELES, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (Nasdaq: TTRX) today announced the launch of a broad communications initiative, featuring a recurring webinar series for shareholders and a forthcoming Founder Blog authore... Full story

Yahoo Finance • 3 months ago

Turn Therapeutics Appoints Arthur Golden to Board of Directors

Turn Therapeutics Veteran corporate advisor to strengthen governance, oversight, and strategic execution as the Company advances late-stage programs WESTLAKE VILLAGE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (“Turn” or... Full story